|
FAM54A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.311200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.043400E-01 |
| Normal-vs-Stage2 |
6.625000E-01 |
| Normal-vs-Stage3 |
2.696400E-01 |
| Normal-vs-Stage4 |
1.349210E-01 |
| Stage1-vs-Stage2 |
1.501000E-03 |
| Stage1-vs-Stage3 |
8.054000E-01 |
| Stage1-vs-Stage4 |
2.698200E-01 |
| Stage2-vs-Stage3 |
2.381500E-03 |
| Stage2-vs-Stage4 |
2.657400E-03 |
| Stage3-vs-Stage4 |
3.778000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.077800E-01 |
| Normal-vs-AfricanAmerican |
8.826200E-01 |
| Normal-vs-Asian |
4.223000E-01 |
| Caucasian-vs-AfricanAmerican |
4.786400E-02 |
| Caucasian-vs-Asian |
4.308600E-01 |
| AfricanAmerican-vs-Asian |
3.325800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.865400E-01 |
| Normal-vs-Female |
3.593800E-01 |
| Male-vs-Female |
6.365000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.826390E-01 |
| Normal-vs-Age(41-60Yrs) |
6.477000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.831800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.301000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.840180E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.396200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.256000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.546400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.878000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.002000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.940300E-02 |
| Classical-VS-Follicular |
3.80509999953205E-07 |
| Classical-VS-Other |
6.542800E-01 |
| Classical-VS-Normal |
1.989970E-01 |
| Tall-VS-Follicular |
1.98730000011693E-07 |
| Tall-VS-Other |
1.253560E-01 |
| Tall-VS-Normal |
1.814340E-02 |
| Follicular-VS-Other |
2.304400E-01 |
| Follicular-VS-Normal |
5.206200E-01 |
| Other-VS-Normal |
6.424600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.916200E-01 |
| Normal-vs-N1 |
2.673400E-01 |
| N0-vs-N1 |
1.894950E-01 |
|
|
